Novo Nordisk

NVO

292 Followers

$65.72

+1.35%

$0.88

6 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

NVO Fair Price

$67.93

Undervalued by 60.4%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Novo Nordisk A/S (NVO) is a Danish pharmaceutical company specializing in the development, manufacturing, and sale of medicines for the treatment of diabetes and other endocrine and metabolic disorders. The company is one of the world's leading manufacturers of insulin and insulin-related medications, which are essential for diabetes treatment. Novo Nordisk also offers other pharmaceutical products for the treatment of obesity, hemophilia, and various endocrine disorders. The company emphasizes on research and innovation in the field of diabetes and other endocrine diseases and has long been committed to fighting diabetes and obesity. Novo Nordisk A/S has extensive international operations, and its products are available in more than 170 countries. Shares of Novo Nordisk A/S (NVO) could represent an intriguing investment opportunity for those who believe in the long-term demand for diabetes and metabolic medications.